Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 26.96 Billion JPY | -39.56% |
| 2023 | 44.61 Billion JPY | 115.06% |
| 2022 | 20.74 Billion JPY | -65.31% |
| 2021 | 59.79 Billion JPY | -24.59% |
| 2020 | 79.29 Billion JPY | -22.38% |
| 2019 | 102.15 Billion JPY | -39.33% |
| 2018 | 168.38 Billion JPY | -27.93% |
| 2017 | 233.63 Billion JPY | 234.6% |
| 2016 | 69.82 Billion JPY | -27.23% |
| 2015 | 95.96 Billion JPY | 44.12% |
| 2014 | 66.58 Billion JPY | -35.37% |
| 2013 | 103.03 Billion JPY | -8.54% |
| 2012 | 112.65 Billion JPY | 235.95% |
| 2011 | -82.86 Billion JPY | -19.37% |
| 2010 | -69.42 Billion JPY | -121.7% |
| 2009 | -31.31 Billion JPY | 40.18% |
| 2008 | -52.34 Billion JPY | -19.33% |
| 2007 | -43.86 Billion JPY | 0.28% |
| 2006 | -43.98 Billion JPY | -0.67% |
| 2005 | -43.69 Billion JPY | -129.22% |
| 2004 | -19.06 Billion JPY | -665.33% |
| 2003 | 3.37 Billion JPY | 223.61% |
| 2002 | -2.72 Billion JPY | 70.05% |
| 2001 | -9.1 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 68.77 Billion JPY | 54.15% |
| 2024 Q4 | 26.96 Billion JPY | -56.92% |
| 2024 FY | 26.96 Billion JPY | -39.56% |
| 2024 Q3 | 62.58 Billion JPY | 42.05% |
| 2024 Q2 | 44.06 Billion JPY | -35.94% |
| 2023 Q3 | 69.31 Billion JPY | 155.62% |
| 2023 FY | 44.61 Billion JPY | 115.06% |
| 2023 Q1 | 25.93 Billion JPY | 25.01% |
| 2023 Q2 | 27.11 Billion JPY | 4.57% |
| 2023 Q4 | 44.61 Billion JPY | -35.64% |
| 2022 FY | 20.74 Billion JPY | -65.31% |
| 2022 Q3 | 47.96 Billion JPY | 0.39% |
| 2022 Q4 | 20.74 Billion JPY | -56.75% |
| 2022 Q2 | 47.77 Billion JPY | -24.69% |
| 2022 Q1 | 63.43 Billion JPY | 6.09% |
| 2021 Q2 | 87.8 Billion JPY | -1.77% |
| 2021 FY | 59.79 Billion JPY | -24.59% |
| 2021 Q4 | 59.79 Billion JPY | -30.04% |
| 2021 Q3 | 85.47 Billion JPY | -2.66% |
| 2021 Q1 | 89.39 Billion JPY | 12.73% |
| 2020 FY | 79.29 Billion JPY | -22.38% |
| 2020 Q3 | 94.28 Billion JPY | -0.72% |
| 2020 Q4 | 79.29 Billion JPY | -15.9% |
| 2020 Q1 | 112.29 Billion JPY | 9.92% |
| 2020 Q2 | 94.97 Billion JPY | -15.42% |
| 2019 Q1 | 158.17 Billion JPY | -6.06% |
| 2019 FY | 102.15 Billion JPY | -39.33% |
| 2019 Q4 | 102.15 Billion JPY | -10.89% |
| 2019 Q2 | 97.63 Billion JPY | -38.28% |
| 2019 Q3 | 114.63 Billion JPY | 17.42% |
| 2018 Q2 | 212.59 Billion JPY | -9.4% |
| 2018 Q3 | 204.64 Billion JPY | -3.74% |
| 2018 Q4 | 168.38 Billion JPY | -17.72% |
| 2018 Q1 | 234.64 Billion JPY | 0.43% |
| 2018 FY | 168.38 Billion JPY | -27.93% |
| 2017 Q1 | 79.88 Billion JPY | 14.4% |
| 2017 FY | 233.63 Billion JPY | 234.6% |
| 2017 Q4 | 233.63 Billion JPY | 179.76% |
| 2017 Q3 | 83.51 Billion JPY | -7.16% |
| 2017 Q2 | 89.95 Billion JPY | 12.61% |
| 2016 Q1 | 102.74 Billion JPY | 7.07% |
| 2016 FY | 69.82 Billion JPY | -27.23% |
| 2016 Q4 | 69.82 Billion JPY | -22.78% |
| 2016 Q3 | 90.42 Billion JPY | 5.09% |
| 2016 Q2 | 86.05 Billion JPY | -16.25% |
| 2015 Q1 | 83.42 Billion JPY | 25.28% |
| 2015 FY | 95.96 Billion JPY | 44.12% |
| 2015 Q4 | 95.96 Billion JPY | -36.68% |
| 2015 Q2 | 63.27 Billion JPY | -24.16% |
| 2015 Q3 | 151.54 Billion JPY | 139.52% |
| 2014 Q2 | 90.19 Billion JPY | -12.53% |
| 2014 Q3 | 82.76 Billion JPY | -8.23% |
| 2014 FY | 66.58 Billion JPY | -35.37% |
| 2014 Q1 | 103.11 Billion JPY | 0.08% |
| 2014 Q4 | 66.58 Billion JPY | -19.55% |
| 2013 Q1 | 120.56 Billion JPY | 7.02% |
| 2013 FY | 103.03 Billion JPY | -8.54% |
| 2013 Q4 | 103.03 Billion JPY | -8.94% |
| 2013 Q3 | 113.15 Billion JPY | -0.28% |
| 2013 Q2 | 113.47 Billion JPY | -5.88% |
| 2012 Q3 | 127.15 Billion JPY | 0.89% |
| 2012 FY | 112.65 Billion JPY | 235.95% |
| 2012 Q1 | 137.77 Billion JPY | 266.27% |
| 2012 Q2 | 126.03 Billion JPY | -8.53% |
| 2012 Q4 | 112.65 Billion JPY | -11.41% |
| 2011 Q1 | -63.03 Billion JPY | 9.2% |
| 2011 Q3 | -65.82 Billion JPY | 7.63% |
| 2011 Q2 | -71.26 Billion JPY | -13.06% |
| 2011 Q4 | -82.86 Billion JPY | -25.88% |
| 2011 FY | -82.86 Billion JPY | -19.37% |
| 2010 FY | -69.42 Billion JPY | -121.7% |
| 2010 Q4 | -69.42 Billion JPY | -32.05% |
| 2010 Q3 | -52.57 Billion JPY | -6.13% |
| 2010 Q2 | -49.53 Billion JPY | 0.0% |
| 2009 Q4 | -31.31 Billion JPY | -58.51% |
| 2009 Q3 | -19.75 Billion JPY | 0.0% |
| 2009 FY | -31.31 Billion JPY | 40.18% |
| 2008 FY | -52.34 Billion JPY | -19.33% |
| 2007 FY | -43.86 Billion JPY | 0.28% |
| 2006 FY | -43.98 Billion JPY | -0.67% |
| 2005 FY | -43.69 Billion JPY | -129.22% |
| 2004 FY | -19.06 Billion JPY | -665.33% |
| 2003 FY | 3.37 Billion JPY | 223.61% |
| 2002 FY | -2.72 Billion JPY | 70.05% |
| 2001 FY | -9.1 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -5621930.269% |
| Ansell Limited | -54.99 Million USD | 49130.062% |
| Ansell Limited | -55.1 Million USD | 49038.294% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 73990.547% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 25656129.381% |
| Psykey, Inc. | 634.59 Thousand USD | -4249080.183% |
| ConvaTec Group Plc | 1.2 Billion USD | -2145.956% |
| ConvaTec Group Plc | 1.2 Billion USD | -2142.785% |
| Encision Inc. | 1.29 Million USD | -2089087.746% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -1167864.718% |
| Innovative MedTech Inc. | 1.76 Million USD | -1527890.589% |
| LifePoint, Inc. | -3.26 Million USD | 826228.263% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -549736.854% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -1247124.792% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 62269174.45% |
| Reflect Scientific, Inc. | -1.03 Million USD | 2604641.455% |
| SmileDirectClub, Inc. | 778.67 Million USD | -3362.925% |
| Sector 10, Inc. | 163 Thousand USD | -16542844.785% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 6557.844% |
| SheerVision, Inc. | 57.34 Thousand USD | -47019028.494% |
| United Health Products, Inc. | 660.56 Thousand USD | -4081986.807% |
| Vasamed, Inc. | 22.12 Thousand USD | -121892133.975% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -1024710.174% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -3491513.782% |